Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,028 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501).
Terashima M, Iwasaki Y, Mizusawa J, Katayama H, Nakamura K, Katai H, Yoshikawa T, Ito Y, Kaji M, Kimura Y, Hirao M, Yamada M, Kurita A, Takagi M, Boku N, Sano T, Sasako M; Stomach Cancer Study Group, Japan Clinical Oncology Group. Terashima M, et al. Gastric Cancer. 2019 Sep;22(5):1044-1052. doi: 10.1007/s10120-019-00941-z. Epub 2019 Mar 2. Gastric Cancer. 2019. PMID: 30827001 Clinical Trial.
Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: exploratory analysis of the JCOG1001 phase III trial.
Misawa K, Kurokawa Y, Mizusawa J, Takiguchi S, Doki Y, Makino S, Choda Y, Takeno A, Tokunaga M, Sano T, Sasako M, Yoshikawa T, Terashima M; Stomach Cancer Study Group of the Japan Clinical Oncology Group. Misawa K, et al. Among authors: terashima m. Gastric Cancer. 2022 Mar;25(2):459-467. doi: 10.1007/s10120-021-01266-6. Epub 2021 Nov 19. Gastric Cancer. 2022. PMID: 34797440 Clinical Trial.
The earlier the better?
Terashima M. Terashima M. Gastric Cancer. 2014 Apr;17(2):197-9. doi: 10.1007/s10120-013-0287-1. Gastric Cancer. 2014. PMID: 23959609 No abstract available.
Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial.
Yang HK, Ji J, Han SU, Terashima M, Li G, Kim HH, Law S, Shabbir A, Song KY, Hyung WJ, Kosai NR, Kono K, Misawa K, Yabusaki H, Kinoshita T, Lau PC, Kim YW, Rao JR, Ng E, Yamada T, Yoshida K, Park DJ, Tai BC, So JBY; EXPEL study group. Yang HK, et al. Among authors: terashima m. Lancet Gastroenterol Hepatol. 2021 Feb;6(2):120-127. doi: 10.1016/S2468-1253(20)30315-0. Epub 2020 Nov 27. Lancet Gastroenterol Hepatol. 2021. PMID: 33253659 Clinical Trial.
Some reactions of 6-formylsafrole. II.
SUGASAWA S, YOSHIDA N, TERASHIMA M. SUGASAWA S, et al. Among authors: terashima m. Pharm Bull. 1954 Jun;2(2):149-51. doi: 10.1248/cpb1953.2.149. Pharm Bull. 1954. PMID: 13215023 No abstract available.
Predictive and prognostic value of excision repair cross-complementing group 1 in patients with advanced gastric cancer.
Yamada Y, Nagashima K, Azuma M, Masutani M, Ichikawa H, Iwasa S, Takahashi N, Hirano H, Kanato K, Machida N, Kinoshita T, Hata H, Kawakami H, Takahari D, Boku N, Kurokawa Y, Terashima M, Yoshikawa T, Sekine S, Hiraoka N. Yamada Y, et al. Among authors: terashima m. BJC Rep. 2024 Mar 5;2(1):18. doi: 10.1038/s44276-024-00046-w. BJC Rep. 2024. PMID: 39516666 Free PMC article.
1,028 results